A metabolomics-based approach for non-invasive screening of fetal central nervous system anomalies
- 25 May 2018
- journal article
- research article
- Published by Springer Science and Business Media LLC in Metabolomics
- Vol. 14 (6), 77
- https://doi.org/10.1007/s11306-018-1370-8
Abstract
Central nervous system anomalies represent a wide range of congenital birth defects, with an incidence of approximately 1% of all births. They are currently diagnosed using ultrasound evaluation. However, there is strong need for a more accurate and less operator-dependent screening method.Funding Information
- FARBS 2016
This publication has 44 references indexed in Scilit:
- Second Trimester Maternal Urine for the Diagnosis of Trisomy 21 and Prediction of Poor Pregnancy OutcomesJournal of Proteome Research, 2013
- Metscape 2 bioinformatics tool for the analysis and visualization of metabolomics and gene expression dataBioinformatics, 2011
- Fetal central nervous system malformations on MR imagesBrain & Development, 2009
- Research electronic data capture (REDCap)—A metadata-driven methodology and workflow process for providing translational research informatics supportJournal of Biomedical Informatics, 2008
- The Edinburgh human metabolic network reconstruction and its functional analysisMolecular Systems Biology, 2007
- The battle of HelsinkiEMBO Reports, 2006
- Correlation of prenatal ultrasound diagnosis and pathologic findings in fetal brain abnormalitiesUltrasound in Obstetrics & Gynecology, 2000
- Partial Least Squares Projections to Latent Structures (PLS) in ChemistryPublished by Wiley ,1998
- Support-vector networksMachine Learning, 1995
- The Honeybee Syndrome — Implications of the Teratogenicity of Mannose in Rat-Embryo CultureThe New England Journal of Medicine, 1984